Company: BOLT
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0000950170-25-069188
Chunk: 0

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
BOLT BIOTHERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS 

(Unaudited, in thousands, except share and per share amounts) 

     March 31,

     December 31,

     2025

     2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     8,391

     $
     7,205

     Short-term investments

     30,447

     40,118

     Restricted cash

     784

     784

     Prepaid expenses and other current assets

     2,887

     2,707

     Total current assets

     42,509

     50,814

     Property and equipment, net

     2,065

     3,139

     Operating lease right-of-use assets

     21,141

     21,756

     Restricted cash, non-current

     981

     981

     Long-term investments

     19,115

     22,880

     Other assets

     51

     62

     Total assets
      
     $
     85,862

     $
     99,632

     Liabilities and stockholders' equity

     Current liabilities:

     Accounts payable
      
     $
     1,534

     $
     1,507

     Accrued expenses and other current liabilities

     6,545

     9,083

     Deferred revenue

     3,083

     3,015

     Operating lease liabilities

     2,400

     2,251

     Total current liabilities

     13,562

     15,856

     Operating lease liabilities, net of current portion

     22,309

     22,958

     Deferred revenue, non-current

     3,049

     3,620

     Other long-term liabilities

     132

     —

     Total liabilities

     39,052

     42,434

     Commitments and contingencies (Note 6)

     Stockholders' equity:

     Common stock, $0.00001 par value; 200,000,000 shares authorized at March 31, 2025 and December 31, 2024; 38,339,697 shares issued and outstanding at March 31, 2025 and December